Annual EPS
-$5.20
+$4.40+45.83%
31 December 2023
Summary:
Cidara Therapeutics annual earnings per share is currently -$5.20, with the most recent change of +$4.40 (+45.83%) on 31 December 2023. During the last 3 years, it has risen by +$30.80 (+85.56%). CDTX annual EPS is now at all-time high.CDTX EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$2.45
+$17.54+87.74%
30 September 2024
Summary:
Cidara Therapeutics quarterly earnings per share is currently -$2.45, with the most recent change of +$17.54 (+87.74%) on 30 September 2024. Over the past year, it has dropped by -$0.43 (-21.29%). CDTX quarterly EPS is now -168.06% below its all-time high of $3.60, reached on 30 June 2021.CDTX Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$25.36
-$0.43-1.72%
30 September 2024
Summary:
Cidara Therapeutics TTM earnings per share is currently -$25.36, with the most recent change of -$0.43 (-1.72%) on 30 September 2024. Over the past year, it has dropped by -$17.12 (-207.77%). CDTX TTM EPS is now -799.29% below its all-time high of -$2.82, reached on 30 June 2023.CDTX TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDTX EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.8% | -21.3% | -207.8% |
| 3 y3 years | +85.6% | +66.9% | -18.5% |
| 5 y5 years | +90.3% | -253.1% | +10.1% |
CDTX EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +85.6% | -172.1% | +87.7% | -799.3% | at low |
| 5 y | 5 years | at high | +90.3% | -168.1% | +87.7% | -799.3% | +29.9% |
| alltime | all time | at high | +92.2% | -168.1% | +89.2% | -799.3% | +64.3% |
Cidara Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.45(-87.7%) | -$25.36(+1.7%) |
| June 2024 | - | -$19.99(+776.8%) | -$24.93(+213.2%) |
| Mar 2024 | - | -$2.28(+256.3%) | -$7.96(+56.7%) |
| Dec 2023 | -$5.20(-45.8%) | -$0.64(-68.3%) | -$5.08(-38.3%) |
| Sept 2023 | - | -$2.02(-33.1%) | -$8.24(+192.2%) |
| June 2023 | - | -$3.02(-603.3%) | -$2.82(-21.7%) |
| Mar 2023 | - | $0.60(-115.8%) | -$3.60(-62.5%) |
| Dec 2022 | -$9.60(-40.7%) | -$3.80(-211.8%) | -$9.60(-12.7%) |
| Sept 2022 | - | $3.40(-189.5%) | -$11.00(-49.5%) |
| June 2022 | - | -$3.80(-29.6%) | -$21.80(+51.4%) |
| Mar 2022 | - | -$5.40(+3.8%) | -$14.40(-14.3%) |
| Dec 2021 | -$16.20(-55.0%) | -$5.20(-29.7%) | -$16.80(-21.5%) |
| Sept 2021 | - | -$7.40(-305.6%) | -$21.40(-3.6%) |
| June 2021 | - | $3.60(-146.2%) | -$22.20(-36.2%) |
| Mar 2021 | - | -$7.80(-20.4%) | -$34.80(-3.9%) |
| Dec 2020 | -$36.00(+31.4%) | -$9.80(+19.5%) | -$36.20(+4.0%) |
| Sept 2020 | - | -$8.20(-8.9%) | -$34.80(+39.2%) |
| June 2020 | - | -$9.00(-2.2%) | -$25.00(-1.6%) |
| Mar 2020 | - | -$9.20(+9.5%) | -$25.40(-8.6%) |
| Dec 2019 | -$27.40 | -$8.40(-625.0%) | -$27.80(-1.4%) |
| Sept 2019 | - | $1.60(-117.0%) | -$28.20(-28.8%) |
| June 2019 | - | -$9.40(-19.0%) | -$39.60(-25.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$11.60(+31.8%) | -$52.80(-7.7%) |
| Dec 2018 | -$53.60(-15.7%) | -$8.80(-10.2%) | -$57.20(-8.0%) |
| Sept 2018 | - | -$9.80(-56.6%) | -$62.20(-7.2%) |
| June 2018 | - | -$22.60(+41.3%) | -$67.00(+4.4%) |
| Mar 2018 | - | -$16.00(+15.9%) | -$64.20(0.0%) |
| Dec 2017 | -$63.60(-4.2%) | -$13.80(-5.5%) | -$64.20(-5.6%) |
| Sept 2017 | - | -$14.60(-26.3%) | -$68.00(-4.2%) |
| June 2017 | - | -$19.80(+23.8%) | -$71.00(+4.1%) |
| Mar 2017 | - | -$16.00(-9.1%) | -$68.20(+2.7%) |
| Dec 2016 | -$66.40(+2.2%) | -$17.60(0.0%) | -$66.40(+5.1%) |
| Sept 2016 | - | -$17.60(+3.5%) | -$63.20(+7.1%) |
| June 2016 | - | -$17.00(+19.7%) | -$59.00(+9.7%) |
| Mar 2016 | - | -$14.20(-1.4%) | -$53.80(+7.1%) |
| Dec 2015 | -$65.00(+246.9%) | -$14.40(+7.5%) | -$50.21(+16.4%) |
| Sept 2015 | - | -$13.40(+13.6%) | -$43.14(-16.1%) |
| June 2015 | - | -$11.80(+11.2%) | -$51.39(-15.2%) |
| Mar 2015 | - | -$10.61(+44.9%) | -$60.60(+11.0%) |
| Dec 2014 | -$18.74(+113.7%) | -$7.32(-66.2%) | -$54.60(+15.5%) |
| Sept 2014 | - | -$21.66(+3.1%) | -$47.27(+84.5%) |
| June 2014 | - | -$21.00(+355.3%) | -$25.62(+455.3%) |
| Mar 2014 | - | -$4.61 | -$4.61 |
| Dec 2013 | -$8.77 | - | - |
FAQ
- What is Cidara Therapeutics annual earnings per share?
- What is the all time high annual EPS for Cidara Therapeutics?
- What is Cidara Therapeutics annual EPS year-on-year change?
- What is Cidara Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Cidara Therapeutics?
- What is Cidara Therapeutics quarterly EPS year-on-year change?
- What is Cidara Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Cidara Therapeutics?
- What is Cidara Therapeutics TTM EPS year-on-year change?
What is Cidara Therapeutics annual earnings per share?
The current annual EPS of CDTX is -$5.20
What is the all time high annual EPS for Cidara Therapeutics?
Cidara Therapeutics all-time high annual earnings per share is -$5.20
What is Cidara Therapeutics annual EPS year-on-year change?
Over the past year, CDTX annual earnings per share has changed by +$4.40 (+45.83%)
What is Cidara Therapeutics quarterly earnings per share?
The current quarterly EPS of CDTX is -$2.45
What is the all time high quarterly EPS for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly earnings per share is $3.60
What is Cidara Therapeutics quarterly EPS year-on-year change?
Over the past year, CDTX quarterly earnings per share has changed by -$0.43 (-21.29%)
What is Cidara Therapeutics TTM earnings per share?
The current TTM EPS of CDTX is -$25.36
What is the all time high TTM EPS for Cidara Therapeutics?
Cidara Therapeutics all-time high TTM earnings per share is -$2.82
What is Cidara Therapeutics TTM EPS year-on-year change?
Over the past year, CDTX TTM earnings per share has changed by -$17.12 (-207.77%)